Associated Papers
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53.
Calheiros J et al.
Biochimica Et Biophysica Acta. Reviews on Cancer, 2023
BRCA1/BRCA2 mutation spectrum analysis in South Asia: a systematic review.
Kharel S et al.
The Journal of International Medical Research, 2022
35000471 (PubMed )
Supplement: sj-pdf-3-imr-10.1177_03000605211070757.pdf
Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes.
Gouvêa Moreira TC et al.
Biomedica : Revista Del Instituto Nacional De Salud, 2021
Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus.
Capoluongo E et al.
Oncotarget, 2018
Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.
Wen WX et al.
Journal of Medical Genetics, 2018
28993434 (PubMed )
Supplement: jmedgenet-2017-104947supp001.pdf
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India.
Mehta A et al.
Cancer Management and Research, 2018
Select a paper to view details